大型多中心队列横断面研究中插管后喉气管狭窄风险与COVID-19状态的关系
该回顾性横断面住院数据库研究纳入美国中西部11家学术与社区医院2020年1月至2022年8月接受机械通气的成人患者,其中COVID-19阴性6851例、阳性1316例,比较插管后6个月内再入院并新诊断喉气管狭窄(LTS)的发生率。COVID-19阳性组LTS发生率为12.7%(168例),阴性组为6.4%(440例),P<0.001,且最常在插管后60天内诊断。多因素分析显示,每增加1个ICU日LTS风险增加2%(HR 1.02,95%CI 1.02-1.03,P<0.001),每增加1天机械通气风险增加3%(HR 1.03,95%CI 1.02-1.04,P<0.001),每增加1次再插管风险增加52%(HR 1.52,95%CI 1.36-1.71,P<0.001);COVID-19状态与LTS风险无显著关联。提示临床应关注插管时长、ICU停留和再插管次数以降低LTS风险。
要点
- COVID-19阳性组插管后LTS发生率为12.7%(168例),阴性组为6.4%(440例),P<0.001,阳性组翻倍。
- LTS最常在插管后60天内被诊断。
- 每增加1个ICU日,LTS风险增加2%(HR 1.02,95%CI 1.02-1.03,P<0.001)。
- 每增加1天机械通气,LTS风险增加3%(HR 1.03,95%CI 1.02-1.04,P<0.001);每增加1次再插管,风险增加52%(HR 1.52,95%CI 1.36-1.71,P<0.001)。
- 多因素分析中COVID-19状态与LTS风险无显著关联,不是独立危险因素。
适用人群与场景
- 美国中西部11家学术与社区医院2020年1月至2022年8月接受机械通气的成人患者,插管后6个月内再入院并新诊断LTS者纳入分析。
- 共纳入COVID-19阴性6851例和COVID-19阳性1316例,两组年龄(中位数63.77岁 vs 63.16岁)、性别(男性60.8%,n=4173 vs 60%,n=789)、气管导管尺寸(≥7.5,75.8%,n=5192 vs 75.5%,n=994)和合并症分布相似。
研究设计与关键结果
- 研究类型为回顾性横断面住院数据库研究,纳入美国中西部11家学术与社区医院2020年1月至2022年8月接受机械通气的成人患者,比较COVID-19阳性与阴性组插管后6个月内再入院新诊断LTS的发生率。
- COVID-19阳性组ICU停留时间中位数7.23天(IQR 2.13-16.67天)长于阴性组3.95天(IQR 1.91-8.88天);机械通气天数中位数5.57天(IQR 1.01-14.18天)长于阴性组1.37天(IQR 0.35-4.72天)。
- LTS发生率在COVID-19阳性组为12.7%(n=168),阴性组为6.4%(n=440),P<0.001,阳性组翻倍,且最常在插管后60天内诊断。
- 多因素分析中,每增加1个ICU日LTS风险增加2%(HR 1.02,95%CI 1.02-1.03,P<0.001);每增加1天机械通气风险增加3%(HR 1.03,95%CI 1.02-1.04,P<0.001);每增加1次再插管风险增加52%(HR 1.52,95%CI 1.36-1.71,P<0.001)。
- COVID-19状态与LTS风险无显著关联。
证据类型、等级与局限
- 证据类型:回顾性横断面住院数据库研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文结论提示插管后LTS发生率在COVID-19阳性队列中翻倍,风险随插管天数、ICU天数和再插管次数增加而升高,尤其与再插管次数相关;COVID-19状态不是LTS的独立危险因素。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Occurrence of post-intubation laryngotracheal stenosis (LTS) with respect to COVID-19 status.
DESIGN: Retrospective cross-sectional inpatient database.
SETTING: Eleven Midwest academic and community hospitals, United States.
PATIENTS: Adults, mechanically ventilated, from January 2020 to August 2022, who were subsequently readmitted within 6 months with a new diagnosis of LTS.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Six thousand eight hundred fifty-one COVID-19 negative and 1316 COVID-19 positive patients were intubated and had similar distribution by age (median 63.77 vs. 63.16 yr old), sex (male, 60.8%; n = 4173 vs. 60%; n = 789), endotracheal tube size (≥ 7.5, 75.8%; n = 5192 vs. 75.5%; n = 994), and comorbidities. The ICU length of stay (median [interquartile range (IQR)], 7.23 d [2.13-16.67 d] vs. 3.95 d [1.91-8.88 d]) and mechanical ventilation days (median [IQR], 5.57 d [1.01-14.18 d] vs. 1.37 d [0.35-4.72 d]) were longer in the COVID-19 positive group. The occurrence of LTS was double in the COVID-19 positive group (12.7%, n = 168 vs. 6.4%, n = 440; p < 0.001) and was most commonly diagnosed within 60 days of intubation. In multivariate analysis, the risk of LTS increased by 2% with each additional ICU day (hazard ratio [HR], 1.02; 95% CI, 1.02-1.03; p < 0.001), by 3% with each additional day of ventilation (HR, 1.03; 95% CI, 1.02-1.04; p < 0.001), and by 52% for each additional reintubation (HR, 1.52; 95% CI, 1.36-1.71; p < 0.001). We observed no significant association COVID-19 status and risk of LTS.
CONCLUSIONS: The occurrence of post-intubation LTS was double in a COVID-19 positive cohort, with higher risk with increasing number of days intubated, days in the ICU and especially with the number of reintubations. COVID-19 status was not an independent risk factor for LTS.
参考来源
- Gray R, Pradhan PM, Hoffmeister J, et al. Risk of Post-Intubation Laryngotracheal Stenosis With Respect to COVID-19 Status in a Large Multicenter Cohort Cross-Sectional Study. Crit Care Explor. 2024. PMID: 38638181. doi:10.1097/CCE.0000000000001081
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。